Jiangsu Lanfeng Bio-chemical Co Ltd (002513) - Total Assets

Latest as of June 2026: CN¥4.08 Billion CNY ≈ $597.33 Million USD

Based on the latest financial reports, Jiangsu Lanfeng Bio-chemical Co Ltd (002513) holds total assets worth CN¥4.08 Billion CNY (≈ $597.33 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Jiangsu Lanfeng Bio-chemical Co Ltd - Total Assets Trend (2007–2025)

This chart illustrates how Jiangsu Lanfeng Bio-chemical Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see Jiangsu Lanfeng Bio-chemical Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Jiangsu Lanfeng Bio-chemical Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Jiangsu Lanfeng Bio-chemical Co Ltd's total assets of CN¥4.08 Billion consist of 51.3% current assets and 48.7% non-current assets. Review 002513 total debt and obligations to assess the company's total debt and financial obligations.

Asset Category Amount (CNY) % of Total Assets
Cash & Equivalents CN¥0.00 20.0%
Accounts Receivable CN¥656.53 Million 14.7%
Inventory CN¥297.07 Million 6.6%
Property, Plant & Equipment CN¥0.00 0.0%
Intangible Assets CN¥62.51 Million 1.4%
Goodwill CN¥0.00 0.0%

Asset Composition Trend (2007–2025)

This chart illustrates how Jiangsu Lanfeng Bio-chemical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Jiangsu Lanfeng Bio-chemical Co Ltd stock price for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Jiangsu Lanfeng Bio-chemical Co Ltd's current assets represent 51.3% of total assets in 2025, an increase from 44.7% in 2007.
  • Cash Position: Cash and equivalents constituted 20.0% of total assets in 2025, up from 6.5% in 2007.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 7.0% in 2007.
  • Asset Diversification: The largest asset category is accounts receivable at 14.7% of total assets.

Jiangsu Lanfeng Bio-chemical Co Ltd Competitors by Total Assets

Key competitors of Jiangsu Lanfeng Bio-chemical Co Ltd based on total assets are shown below.

Company Country Total Assets
Qinghai Salt Lake Industry Co.Ltd
SHE:000792
China CN¥61.57 Billion
Yunnan Yuntianhua Co Ltd
SHG:600096
China CN¥52.79 Billion
Chengdu Wintrue Holding Co Ltd
SHE:002539
China CN¥27.76 Billion
Tessenderlo
BR:TESB
Belgium €2.64 Billion
Fanli Digital Technology Co Ltd
SHG:600228
China CN¥575.15 Million
Sichuan Meifeng Chemical Industry Co Ltd
SHE:000731
China CN¥5.17 Billion
Anhui Huilong Agricultural Means of Production Co Ltd
SHE:002556
China CN¥11.55 Billion
Jiangsu Fengshan Group Co Ltd
SHG:603810
China CN¥2.74 Billion

Jiangsu Lanfeng Bio-chemical Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.65 0.63 0.69
Quick Ratio 0.55 0.53 0.55
Cash Ratio 0.00 0.00 0.00
Working Capital CN¥-1.11 Billion CN¥-1.12 Billion CN¥-323.78 Million

Jiangsu Lanfeng Bio-chemical Co Ltd - Advanced Valuation Insights

This section examines the relationship between Jiangsu Lanfeng Bio-chemical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 407.48
Latest Market Cap to Assets Ratio 0.06
Asset Growth Rate (YoY) 30.9%
Total Assets CN¥4.48 Billion
Market Capitalization $287.45 Million USD

Valuation Analysis

Below Book Valuation: The market values Jiangsu Lanfeng Bio-chemical Co Ltd's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Jiangsu Lanfeng Bio-chemical Co Ltd's assets grew by 30.9% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Jiangsu Lanfeng Bio-chemical Co Ltd (2007–2025)

The table below shows the annual total assets of Jiangsu Lanfeng Bio-chemical Co Ltd from 2007 to 2025.

Year Total Assets Change
2025-12-31 CN¥4.48 Billion
≈ $655.10 Million
+30.95%
2024-12-31 CN¥3.42 Billion
≈ $500.28 Million
+0.57%
2023-12-31 CN¥3.40 Billion
≈ $497.47 Million
+130.40%
2022-12-31 CN¥1.48 Billion
≈ $215.92 Million
-14.61%
2021-12-31 CN¥1.73 Billion
≈ $252.85 Million
-25.23%
2020-12-31 CN¥2.31 Billion
≈ $338.18 Million
-14.49%
2019-12-31 CN¥2.70 Billion
≈ $395.49 Million
-23.37%
2018-12-31 CN¥3.53 Billion
≈ $516.09 Million
-12.54%
2017-12-31 CN¥4.03 Billion
≈ $590.07 Million
-0.44%
2016-12-31 CN¥4.05 Billion
≈ $592.66 Million
+0.41%
2015-12-31 CN¥4.03 Billion
≈ $590.23 Million
+54.47%
2014-12-31 CN¥2.61 Billion
≈ $382.10 Million
+0.87%
2013-12-31 CN¥2.59 Billion
≈ $378.80 Million
+11.03%
2012-12-31 CN¥2.33 Billion
≈ $341.18 Million
+33.10%
2011-12-31 CN¥1.75 Billion
≈ $256.34 Million
+5.86%
2010-12-31 CN¥1.65 Billion
≈ $242.16 Million
+152.79%
2009-12-31 CN¥654.62 Million
≈ $95.79 Million
+41.84%
2008-12-31 CN¥461.53 Million
≈ $67.54 Million
+21.08%
2007-12-31 CN¥381.17 Million
≈ $55.78 Million
--

About Jiangsu Lanfeng Bio-chemical Co Ltd

SHE:002513 China Agricultural Inputs
Market Cap
$287.45 Million
CN¥1.96 Billion CNY
Market Cap Rank
#15142 Global
#4493 in China
Share Price
CN¥5.23
Change (1 day)
-1.13%
52-Week Range
CN¥4.33 - CN¥10.40
All Time High
CN¥20.11
About

Jiangsu Lanfeng Bio-chemical Co.,Ltd engages in the production and processing of fungicide, insecticide, herbicide technicals and formulations, and chemical products in China and internationally. It offers carbendazim, thiophanate, fluticasone, benzoyl, cymoxanil, iprodione, imidacloprid, acetamiprid, pyrethroid, pyridaben, butylene, acetaminophen, lego, cycloazine, thiophanate-methyl, butylcarbo… Read more